JP2024543111A5 - - Google Patents

Info

Publication number
JP2024543111A5
JP2024543111A5 JP2024529934A JP2024529934A JP2024543111A5 JP 2024543111 A5 JP2024543111 A5 JP 2024543111A5 JP 2024529934 A JP2024529934 A JP 2024529934A JP 2024529934 A JP2024529934 A JP 2024529934A JP 2024543111 A5 JP2024543111 A5 JP 2024543111A5
Authority
JP
Japan
Prior art keywords
gastric cancer
pharmaceutical composition
difluoromethoxy
benzamide
metastatic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024529934A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024543111A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/050289 external-priority patent/WO2023091590A1/en
Publication of JP2024543111A publication Critical patent/JP2024543111A/ja
Publication of JP2024543111A5 publication Critical patent/JP2024543111A5/ja
Pending legal-status Critical Current

Links

JP2024529934A 2021-11-17 2022-11-17 胃がんの治療に使用するための化合物 Pending JP2024543111A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163280540P 2021-11-17 2021-11-17
US63/280,540 2021-11-17
PCT/US2022/050289 WO2023091590A1 (en) 2021-11-17 2022-11-17 Compounds for use in treating gastric cancer

Publications (2)

Publication Number Publication Date
JP2024543111A JP2024543111A (ja) 2024-11-19
JP2024543111A5 true JP2024543111A5 (enExample) 2025-11-18

Family

ID=84887956

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024529934A Pending JP2024543111A (ja) 2021-11-17 2022-11-17 胃がんの治療に使用するための化合物

Country Status (8)

Country Link
US (1) US20250017906A1 (enExample)
EP (1) EP4433051A1 (enExample)
JP (1) JP2024543111A (enExample)
KR (1) KR20240149878A (enExample)
CN (1) CN118488837A (enExample)
AU (1) AU2022390803A1 (enExample)
CA (1) CA3238430A1 (enExample)
WO (1) WO2023091590A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020417293A1 (en) * 2020-01-03 2022-09-01 Berg Llc Polycyclic amides as UBE2K modulators for treating cancer
WO2024216283A1 (en) * 2023-04-13 2024-10-17 Bpgbio, Inc. Microtubule targeting agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10308617B2 (en) * 2016-06-03 2019-06-04 An2H Discovery Limited Triazole benzamide derivatives and the compositions and methods of treatment regarding the same
CA3112191A1 (en) * 2018-09-10 2020-03-19 Berg Llc Methods of treating cancer by inhibiting ubiquitin conjugating enzyme e2 k (ube2k)
AU2020417293A1 (en) 2020-01-03 2022-09-01 Berg Llc Polycyclic amides as UBE2K modulators for treating cancer

Similar Documents

Publication Publication Date Title
JP2021063088A5 (enExample)
JP2016503786A5 (enExample)
JP2024028337A5 (enExample)
JP2022543155A5 (enExample)
JP2002508361A5 (enExample)
JP2024541569A5 (enExample)
IL160028A (en) Thiophene carboxamide derivatives, process for their preparation, pharmaceutical compositions comprising them and their use in therapy
JP2024540183A5 (enExample)
JP2005500357A5 (enExample)
JP2007533687A5 (enExample)
RU2004106779A (ru) Способ профилактики и/или лечения дисфункции и/или нарушения структуры ногтей, пластырь для его осуществления и его применение
JP2020512337A5 (enExample)
JPWO2023195530A5 (enExample)
JP2023545372A5 (enExample)
CN115315423A (zh) 取代芳基类化合物
JP2023156372A5 (enExample)
JP2025508071A5 (enExample)
JP2007500222A5 (enExample)
JP2004525184A5 (enExample)
JP2019065009A5 (enExample)
JP2003518022A5 (enExample)
JP2005527575A5 (enExample)
JP2022517902A5 (enExample)
JP2005513036A5 (enExample)
JP2023527358A5 (enExample)